NEPHROS, INC. Other Expenses
NEPHROS, INC. (NEPH) reported Other Expenses of $29.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherExpenses · last filed 2026-08-10
- NEPHROS, INC. other expenses for the quarter ending 2026-06-30 was $29.00K, a 17.14% decline year-over-year.
- NEPHROS, INC. other expenses for the quarter ending 2026-03-31 was $29.00K, a 25.64% decline year-over-year.
- NEPHROS, INC. other expenses for the quarter ending 2025-12-31 was $32.00K, a 5.88% decline year-over-year.
- NEPHROS, INC. other expenses for the quarter ending 2025-09-30 was $34.00K, a 0.00% change year-over-year.
- NEPHROS, INC. other expenses for fiscal 2025 was $140.00K, a 3.70% increase from fiscal 2024.
- NEPHROS, INC. other expenses for fiscal 2024 was $135.00K, a 36.92% decline from fiscal 2023.
- NEPHROS, INC. other expenses for fiscal 2023 was $214.00K.
- NEPHROS, INC. other expenses for fiscal 2013 was $50.00K.
| Period end | Other Expenses 3 month | Other Expenses 6 month | Other Expenses 9 month | Other Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $29.00K 10-Q · filed 2026-08-10 | $58.00K 10-Q · filed 2026-08-10 | $90.00K derived: sum of 3 quarters · filed 2026-08-10 | $124.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $29.00K 10-Q · filed 2026-05-07 | $61.00K derived: sum of 2 quarters · filed 2026-05-07 | $95.00K derived: sum of 3 quarters · filed 2026-05-07 | $130.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $66.00K derived: sum of 2 quarters · filed 2026-03-12 | $101.00K derived: sum of 3 quarters · filed 2026-08-10 | $140.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $34.00K 10-Q · filed 2025-11-06 | $69.00K derived: sum of 2 quarters · filed 2026-08-10 | $108.00K 10-Q · filed 2025-11-06 | $142.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $35.00K 10-Q · filed 2026-08-10 | $74.00K 10-Q · filed 2026-08-10 | $108.00K derived: sum of 3 quarters · filed 2026-08-10 | $142.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $39.00K 10-Q · filed 2026-05-07 | $73.00K derived: sum of 2 quarters · filed 2026-05-07 | $107.00K derived: sum of 3 quarters · filed 2026-05-07 | $141.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $68.00K derived: sum of 2 quarters · filed 2026-03-12 | $102.00K derived: sum of 3 quarters · filed 2026-03-12 | $135.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $34.00K 10-Q · filed 2025-11-06 | $68.00K derived: sum of 2 quarters · filed 2025-11-06 | $101.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $34.00K 10-Q · filed 2025-08-07 | $67.00K 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $33.00K 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | $214.00K 10-K · filed 2025-03-24 | |||
| 2013-12-31 | $50.00K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |